MedNet is proud to announce its inclusion on the INC 5000 list of fastest growing private companies for the second straight year.
MedNet Included in INC 5000 List
MedNet is proud to announce its inclusion on the INC 5000 list of fastest growing private companies for the second straight year. "We're both proud of our results and humbled by our good fortune and the dedication of our staff," said Rob Robertson President & CEO, "It appears our long term strategy of planned growth is bearing fruit. Ranking at number 36 in the Minneapolis-St Paul-Bloomingtoon-MN-WI region as a whole is very gratifying".
MedNet, a leading provider of eClinical Solutions, is headquatered in Minneapolis Minnesota, and counts Genentech, Teva Pharmaceuticals, AstraZeneca, ImClone, Medtronic and many others amongst its customer list for Studies of all phases conducted in over 40 countries. MedNet's corporate website is www.mednetstudy.com
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.